Stocks and Investing Stocks and Investing
Tue, January 3, 2017
Fri, December 30, 2016
Thu, December 29, 2016
Wed, December 28, 2016
Tue, December 27, 2016
Mon, December 26, 2016
Fri, December 23, 2016
Thu, December 22, 2016
Wed, December 21, 2016

Paul Matteis Initiated (CDTX) at Buy and Held Target at $340 on, Dec 21st, 2016


Published on 2024-10-25 19:45:55 - WOPRAI, Paul Matteis
  Print publication without navigation


Paul Matteis of Leerink Swann, Initiated "Cidara Therapeutics, Inc." (CDTX) at Buy and Held Target at $340 on, Dec 21st, 2016.

Paul has made no other calls on CDTX in the last 4 months.



There are 2 other peers that have a rating on CDTX. Out of the 2 peers that are also analyzing CDTX, 0 agree with Paul's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Paul


  • Ed Arce of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $500 on, Monday, December 19th, 2016
  • Stephen Brozak of "WBB Securities" Downgraded from Hold to Strong Sell on, Friday, September 23rd, 2016